We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App




Takeda to Buy Brazilian Pharmaceutical Company Multilab

By HospiMedica International staff writers
Posted on 05 Jun 2012
Print article
Takeda Pharmaceutical (Osaka, Japan), Asia’s largest drugmaker, has agreed to buy Multilab Industria e Comercio de Productos Farmaceuticos (Multilab; Sao Jeronimo, Brazil), in a move intended to enhance its business infrastructure in Brazil.

The acquisition of Multilab for USD 246 million will position Takeda as one of the top ten pharmaceutical companies in Brazil. Multilab has well established distribution through regional wholesalers and small to mid-sized independent pharmacies, in particular in emerging regions of the country, which is expected to complement Takeda’s strong relationships with major wholesalers, retail chains, and pharmacies in more established cities and state capitals. The transaction is expected to be completed by the end of September 2012.

Takeda already has an established presence in Brazil, manufacturing and marketing both prescription drugs as well as well-known brands such as the analgesic Neosaldina, the digestive Eparema, and Nebacetin, an antibacterial product. Multilab’s leading products include Multigrip, the country’s best selling over the counter (OTC) product for cold and flu treatment, which Takeda believes will be an excellent addition to its existing OTC product line in Brazil.

“This acquisition significantly reinforces Takeda’s position in Brazil, which is the world’s sixth largest economy and the biggest in South America,” said Jostein Davidsen, head of emerging markets commercial operations for Takeda. “Takeda has ambitious plans for growth in emerging markets. Brazil is our second largest emerging market after Russia/CIS in terms of revenues, and the acquisition of Multilab is a clear signal of our intention to become a significant player both in Brazil and other high-growth markets.”

“Multilab will benefit from becoming part of the Takeda group, enabling the company to reinforce its market position and reach more patients with its key products in Brazil,” said Hilton Cavedon, executive director of Multilab.

Related Links:

Takeda Pharmaceutical
Multilab Industria e Comercio de Productos Farmaceuticos


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Hospital Bed
Alphalite
New
LED Surgical Light
Convelar 1670 LED+/1675 LED+/1677 LED+

Print article

Channels

Surgical Techniques

view channel
Image: Schematic diagram of intra-articular pressure detection using a sensory system in a sheep model (Photo courtesy of Science China Press)

Novel Sensory System Enables Real-Time Intra-Articular Pressure Monitoring

Knee replacement surgery is a widely performed procedure to relieve knee pain and restore joint function, with over one million surgeries conducted annually. However, 10%-20% of patients remain dissatisfied... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The acoustic pipette uses sound waves to test for biomarkers in blood (Photo courtesy of Patrick Campbell/CU Boulder)

Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour

Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.